Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769207 · ClinicalTrials.gov registry record · NA
Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
A NA study of Atrial Fibrillation and Atrial Flutter, sponsored by Apple.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03769207 is a NA study of Atrial Fibrillation and Atrial Flutter that has completed, run by Apple. The registered enrollment target is 17 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03769207, a NA study of Atrial Fibrillation and Atrial Flutter, has completed, sponsored by Apple.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.
Conditions Studied
Interventions
- DEVICE Ambulatory ECG
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-12-08 |
| Est. Completion | 2019-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03769207
The ClinicalTrials.gov registry entry for NCT03769207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is Apple, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Ambulatory ECG is the first listed.
NCT03769207 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03769207 about?
NCT03769207 is a clinical study titled "Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias". This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.
What is the current status of trial NCT03769207?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-12-08. Estimated completion is 2019-08-20.
What conditions does trial NCT03769207 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter, Arrhythmias, Cardiac.
What interventions are being tested in trial NCT03769207?
The interventions under investigation include: Ambulatory ECG (DEVICE).
Who is sponsoring clinical trial NCT03769207?
This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03769207 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.